ALLERGEN-SPECIFIC IMMUNOTHERAPY IN CHILDREN WITH POLLINOSIS

Aim: to compare clinical efficacy and safety of sublingual and parenteral allergen-specific immunotherapy in children with pollinosis. Patients and methods: 143 patients with pollinosis aged from 5 to 16 years old were included into the study. They were divided into 4 groups and received allergen-sp...

Full description

Bibliographic Details
Main Authors: R. M. Torshkhoeva, L. S. Namazova-Baranova, O. I. Muradova, A. Yu. Tomilova, N. I. Voznesenskaya
Format: Article
Language:English
Published: "Paediatrician" Publishers LLC 2014-01-01
Series:Voprosy Sovremennoj Pediatrii
Subjects:
Online Access:https://vsp.spr-journal.ru/jour/article/view/242